XML 181 R123.htm IDEA: XBRL DOCUMENT v3.3.1.900
Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Selected Quarterly Financial Information [Abstract]                      
Product, net $ 2,425.9 $ 2,391.7 $ 2,198.6 $ 2,172.3 $ 2,287.0 $ 2,117.3 $ 2,056.3 $ 1,742.8 $ 9,188.5 $ 8,203.4 $ 5,542.3
Unconsolidated joint business revenues 333.9 337.2 337.5 330.6 304.5 290.7 303.3 296.9 1,339.2 1,195.4 1,126.0
Other 79.5 49.0 55.6 52.0 49.2 103.4 61.9 90.1 236.1 304.5 263.9
Total revenues 2,839.3 2,777.9 2,591.6 2,555.0 2,640.7 2,511.4 2,421.5 2,129.8 10,763.8 9,703.3 6,932.2
Gross Profit 2,507.5 2,467.9 2,305.5 2,242.6 2,343.4 2,208.8 2,129.6 1,850.5 9,523.4 8,532.3  
Net income 828.7 1,019.5 924.8 820.2 882.6 856.1 723.1 479.7 3,593.2 2,941.6 1,862.3
Net income attributable to Biogen Idec Inc $ 831.6 $ 965.6 $ 927.3 $ 822.5 $ 883.5 $ 856.9 $ 714.5 $ 480.0 $ 3,547.0 $ 2,934.8 $ 1,862.3
Basic earnings per share attributable to Biogen Inc. $ 3.77 $ 4.16 $ 3.94 $ 3.50 $ 3.75 $ 3.63 $ 3.02 $ 2.03 $ 15.38 $ 12.42 $ 7.86
Diluted earnings per share attributable to Biogen Inc. $ 3.77 $ 4.15 $ 3.93 $ 3.49 $ 3.74 $ 3.62 $ 3.01 $ 2.02 $ 15.34 $ 12.37 $ 7.81
Basic earnings per share attributable to Biogen Inc. 220.4 232.2 235.3 235.0 235.5 236.2 236.7 236.8 230.7 236.4 236.9
Diluted earnings per share attributable to Biogen Inc. 220.8 232.6 235.7 235.6 236.3 237.0 237.4 237.8 231.2 237.2 238.3